Corcept Therapeutics (CORT) Non-Current Debt (2012 - 2016)

Corcept Therapeutics (CORT) has 5 years of Non-Current Debt data on file, last reported at $3.7 million in Q2 2016.

• For the quarter ending Q2 2016, Non-Current Debt fell 80.7% year-over-year to $3.7 million; the trailing twelve-month figure through Jun 2016 stood at $3.7 million (down 80.7% YoY), and the FY2015 full-year result was $12.5 million, down 48.79% from the prior year.
• Non-Current Debt eased to $3.7 million in Q2 2016, from $8.7 million in the prior quarter.
• In the past five years, Non-Current Debt ranged from a high of $30.2 million in Q2 2013 to a low of $3.7 million in Q2 2016.
• A 5-year average of $22.8 million and a median of $26.8 million in 2014 frame the typical range for Non-Current Debt.
• Across the five-year window, Non-Current Debt rose 6.41% in 2013 and slumped 80.7% in 2016, its largest moves.
• Tracing CORT's Non-Current Debt over 5 years: stood at $29.0 million in 2012, then increased by 1.01% to $29.3 million in 2013, then retreated by 16.57% to $24.5 million in 2014, then tumbled by 48.79% to $12.5 million in 2015, then tumbled by 70.11% to $3.7 million in 2016.
• Business Quant data shows CORT's Non-Current Debt at $3.7 million in Q2 2016, $8.7 million in Q1 2016, and $12.5 million in Q4 2015.